Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (3): 734-743.doi: 10.13481/j.1671-587X.20220323
• Research in basic medicine • Previous Articles Next Articles
Qinghui WANG1,Bo LI1(
),Chuancui HU1,Mingchao NIE1,Xiaomei ZHENG2
Received:2021-09-14
Online:2022-05-28
Published:2022-06-21
Contact:
Bo LI
E-mail:poelee@126.com
CLC Number:
Qinghui WANG,Bo LI,Chuancui HU,Mingchao NIE,Xiaomei ZHENG. Effects of miR-107 on regulation of immune escape and taxol resistance of ovarian cancer cells[J].Journal of Jilin University(Medicine Edition), 2022, 48(3): 734-743.
Tab. 4
Expression level of FAS protein of HPBL cells and apoptotic rates of HPBL cells in various groups"
| Group | Expression level of FAS | Apoptotic rate(η/%) |
|---|---|---|
| HPBL | 1.02±0.11 | 6.24±1.77 |
| HPBL+SKOV3/TAX | 2.58±0.30* | 30.45±4.98* |
| HPBL+SKOV3/TAX+TAX | 1.95±0.19△ | 20.33±2.95△△ |
| HPBL+SKOV3/TAX+TAX+miR-107 mimics | 1.54±0.10# | 11.15±2.18# |
| HPBL+SKOV3/TAX+TAX+miR-107 mimics+ pcDNA-MAP3K7 | 2.04±0.19○ | 21.00±3.00○ |
| 1 | STEWART C, RALYEA C, LOCKWOOD S. Ovarian cancer: an integrated review[J]. Semin Oncol Nurs, 2019, 35(2): 151-156. |
| 2 | MCMULLEN M, KARAKASIS K, MADARIAGA A, et al. Overcoming platinum and PARP-inhibitor resistance in ovarian cancer[J]. Cancers, 2020, 12(6): 1607. |
| 3 | LAU T S, CHAN L K Y, MAN G C W, et al. Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4/IKK2/SNARE-dependent exocytosis[J].Cancer Immunol Res,2020,8(8): 1099-1111. |
| 4 | WOLF D, FIEGL H, ZEIMET A G, et al. High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome[J]. Int J Cancer, 2020, 146(7): 2007-2018. |
| 5 | DIECKMANN K P, RADTKE A, GECZI L, et al. Serum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study[J]. J Clin Oncol, 2019, 37(16): 1412-1423. |
| 6 | XIONG Y Q, LIU Z M, LI Z, et al. Long non‑coding RNA nuclear paraspeckle assembly transcript 1 interacts with microRNA‑107 to modulate breast cancer growth and metastasis by targeting carnitine palmitoyltransferase‑1[J]. Int J Oncol, 2019, 55(5): 1125-1136. |
| 7 | CHEN H A, LI C C, LIN Y J, et al. Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cells[J]. Aging, 2021, 13(8): 12046-12057. |
| 8 | SU H W, TAO T, YANG Z, et al. Circular RNA cTFRC acts as the sponge of microRNA-107 to promote bladder carcinoma progression[J]. Mol Cancer, 2019, 18(1): 27. |
| 9 | TANG Z H, FANG Y X, DU R. microRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer[J]. Biochem Biophys Res Commun, 2019, 512(2): 331-337. |
| 10 | LHEUREUX S, BRAUNSTEIN M, OZA A M. Epithelial ovarian cancer: evolution of management in the era of precision medicine[J]. CA Cancer J Clin, 2019, 69(4): 280-304. |
| 11 | UPADHYAY R, BOIARSKY J A, PANTSULAIA G, et al. A critical role for fas-mediated off-target tumor killing in T-cell immunotherapy[J]. Cancer Discov, 2021, 11(3): 599-613. |
| 12 | YAMADA A, ARAKAKI R, SAITO M, et al. Dual role of fas/FasL-mediated signal in peripheral immune tolerance[J]. Front Immunol, 2017, 8: 403. |
| 13 | PARDOLL D M. The blockade of immune checkpoints in cancer immunotherapy[J]. Nat Rev Cancer, 2012, 12(4): 252-264. |
| 14 | IQBAL M A, ARORA S, PRAKASAM G, et al. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance[J]. Mol Aspects Med, 2019, 70: 3-20. |
| 15 | PERRIER A, DIDELOT A, LAURENT-PUIG P,et al.Epigenetic mechanisms of resistance to immune checkpoint inhibitors[J]. Biomolecules, 2020, 10(7): 1061. |
| 16 | FUJITA Y, YAGISHITA S, HAGIWARA K, et al. The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer[J]. Mol Ther, 2015, 23(4): 717-727. |
| 17 | NEVIANI P, WISE P M, MURTADHA M, et al. Natural killer-derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms[J]. Cancer Res, 2019, 79(6): 1151-1164. |
| 18 | JIN D, GUO J W, WU Y, et al. M 6 A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC[J]. Mol Cancer, 2020, 19(1): 40. |
| 19 | WEI J, XU H F, WEI W, et al. circHIPK3 promotes cell proliferation and migration of gastric cancer by sponging miR-107 and regulating BDNF expression[J]. Onco Targets Ther, 2020, 13: 1613-1624. |
| 20 | TIAN X H, WU Y Y, YANG Y T, et al. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling[J]. Mol Oncol, 2020, 14(2): 462-483. |
| 21 | FU Y X, LIN L W, XIA L G. miR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1[J]. Cell Mol Biol Lett, 2019, 24: 31. |
| 22 | WEI X Q, LEI Y J, LI M J, et al. miR-107 inhibited malignant biological behavior of non-small cell lung cancer cells by regulating the STK33/ERK signaling pathway in vivo and vitro [J].J Thorac Dis, 2020,12(4): 1540-1551. |
| 23 | CORDAS DOS SANTOS D M, EILERS J, SOSA VIZCAINO A, et al. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB[J]. BMC Cancer, 2018, 18(1): 663. |
| 24 | LE GOFF C, ROGERS C, LE GOFF W, et al. Heterozygous mutations in MAP3K7, encoding TGF-β-activated kinase 1, cause cardiospondylocarpofacial syndrome[J]. Am J Hum Genet, 2016,99(2): 407-413. |
| 25 | ZHOU L L, DONG J L, HUANG G, et al. microRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer[J]. Braz J Med Biol Res, 2017, 50(8): e5891. |
| 26 | FAN H, GE Y G, MA X, et al. Long non-coding RNA CCDC144NL-AS1 sponges miR-143-3p and regulates MAP3K7 by acting as a competing endogenous RNA in gastric cancer[J]. Cell Death Dis, 2020, 11(7): 521. |
| 27 | ZEHAVI L, SCHAYEK H, JACOB-HIRSCH J, et al. miR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma[J]. Mol Cancer, 2015, 14: 68. |
| 28 | JIN X, DING D L, YAN Y Q, et al. Phosphorylated RB promotes cancer immunity by inhibiting NF-κB activation and PD-L1 expression[J]. Mol Cell, 2019, 73(1): 22-35.e6. |
| [1] | Yao ZHENG,Mingxia FU,Weichen WANG,Weiwei CHEN,Yuchen HAN,Yu BAI,Jiajia AN. Effect of sodium selenite on biological behaviors of breast cancer doxorubicin-resistant MCF-7/ADR cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 410-417. |
| [2] | Li ZHAI,Meng CHEN,Jianbo LUO,Aili ZHANG,Liangxiao WANG,Ying WEI,Xi ZHANG. Targeting relationship between miR-214-3p and EZH2 and its effects on proliferation, invasion, and apoptosis of ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 460-468. |
| [3] | Qiuyuan SU,Ling ZHAO,Jiajia TAN,Shien MO,Haiqin ZHOU,Fangfang LU,Yi WEI,Yang ZHOU,Yan KUANG. Construction of SPHK1 overexpression lentiviral vectors and establishment of stable transfected SKOV3 cell lines [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1709-1716. |
| [4] | Yunxiu XIA,Shuo ZHANG,Huanhai ZHANG,Fei WANG,Hongliang DONG,Jing DU. Long non-coding RNA LINC00973 promotes migration, invasion and distal metastasis of epithelial ovarian cancer and its molecular mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 866-878. |
| [5] | Yan LIU,Beizhen PAN,Jifei YANG,Xianyu ZHANG,Wenbo DING,Lingli SONG,Yundong ZHAO. Expression of quorum sensing related genes in multidrug-resistant Pseudomonas aeruginosa and its effects on biofilm formation and drug resistance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 921-928. |
| [6] | Xiaoshuang HE,Lina XU,Mei CUI,Yu ZHAO,Bei WANG,Zheng HUANG,Yuchao WANG,Wenyan XIN,Chao WU. Effects of lncRNA DUXAP8 in lung cancer A549 cells-derived exosomes on lung cancer cell growth and its mechnism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 958-967. |
| [7] | Yuling GU,Cui ZHENG,Yunxian TANG. Inhibitory effect of silencing of circadian rhythm gene TIMELESS on immune escape of ovarian cancer SK-OV-3 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 653-662. |
| [8] | Shuo ZHANG,Yunxiu XIA,Weiwei CHEN,Hongliang DONG,Bingjie CUI,Cuilan LIU,Zhiqiang LIU,Fei WANG,Jing DU. Effect of over-expression of NR2F2 on biological behaviors of human ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 58-67. |
| [9] | Bingbing HU,Kangning LUO,Su PENG,Yuzhong ZHOU,Maoliang CHEN,Changhua LIU. Improvement effect of down-regulation of miR-208a on 5-FU resistance in colorectal cancer cells through targeting SFRP1 for mediating Wnt signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 947-955. |
| [10] | Zhibo XU,Xinmiao JIANG,Yuqi ZHEN,MA Quzhen BAI,Mengyao SUN,Xiuping MENG. Effect of chlorhexidine on drug resistance and pathogenicity of Enterococcus faecalis and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 676-681. |
| [11] | Ying ZHANG,Zhaohui WAN,Xianxun JIANG. Effect of over-expression of NDRG1 on resistance of castration-resistant prostate cancer resistant cell line C4-2/ENZA and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 708-717. |
| [12] | ERDEMUTU,Yanyan WANG,Yutong LI,Guilin CHEN,Junrui WANG. Comparison of drug resistance of MRSA clinical strains from respiratory tract and non-respiratory tract specimens and their molecular epidemiological characteristics [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 422-430. |
| [13] | Chunyan KANG,Xiuzhi ZHANG,Huicong ZHOU,Jie CHEN. Effect of downregulating proline-rich protein 11 expression on drug resistance of esophageal cancer drug resistant cell EC9706/DDP and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 113-119. |
| [14] | Jia ZHOU,Zhidong QIU,Zhe LIN,Guangfu LYU,Jiaming XU,He LIN,Kexin WANG,Yuchen WANG,Xiaowei HUANG. Effect of chelerythrine on migration, invasion, and epithelial-mesenchymal transition of human ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 25-32. |
| [15] | Jingjing LI, REZIWANGULI·Aisikaier,Wanyi XING,Yinggang ZOU. Primary dedifferentiated liposarcoma of unilateral ovary: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2023, 49(4): 1040-1045. |
|